Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1278863 TIW dosing in anemia of CKD
NCT02689206Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of daprodustat in anemia of chronic kidney disease (CKD-A), sponsored by GSK. Started Feb 2016; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02689206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02689206.